{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:34:47Z","timestamp":1784770487219,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bmc.2024.117908","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:59:51Z","timestamp":1725523191000},"page":"117908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Targeting the PI3K\/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential"],"prefix":"10.1016","volume":"115","author":[{"given":"Zhengyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-6748","authenticated-orcid":false,"given":"Mingliang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117908_b0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bmc.2024.117908_b0010","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bmc.2024.117908_b0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.bmc.2024.117908_b0020","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2024.117908_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2024.117908_b0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd.2017.170","article-title":"Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease","volume":"16","author":"Mora","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117908_b0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thoraxjnl-2015-207429","article-title":"Exploration of a potent PI3 kinase\/mTOR inhibitor as a novel anti-fibrotic agent in IPF","volume":"71","author":"Mercer","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.bmc.2024.117908_b0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2024.117908_b0045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bmc.2024.117908_b0050","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/onc.2011.414","article-title":"Differential roles for the p101 and p84 regulatory subunits of PI3Kgamma in tumor growth and metastasis","volume":"31","author":"Brazzatti","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2024.117908_b0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tibs.2009.01.003","article-title":"Regulation of phosphoinositide 3-kinase expression in health and disease","volume":"34","author":"Kok","year":"2009","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bmc.2024.117908_b0060","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.94.9.4330","article-title":"P110delta, a novel phosphoinositide 3-kinase in leukocytes","volume":"94","author":"Vanhaesebroeck","year":"1997","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117908_b0065","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1042\/BCJ20160170","article-title":"The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34","volume":"473","author":"Backer","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.117908_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20071427","article-title":"The regulation and function of Class III PI3Ks: novel roles for Vps34","volume":"410","author":"Backer","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.117908_b0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cellsig.2009.01.012","article-title":"Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms","volume":"21","author":"Dunlop","year":"2009","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.bmc.2024.117908_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010018","article-title":"mTOR: a cellular regulator interface in health and disease","volume":"8","author":"Boutouja","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2024.117908_b0085","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression","volume":"23","author":"Fingar","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2024.117908_b0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117908_b0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj3460561","article-title":"The PI3K-PDK1 connection: more than just a road to PKB","volume":"346","author":"Vanhaesebroeck","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.117908_b0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2024.117908_b0105","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2024.117908_b0110","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1111\/jcmm.13725","article-title":"Astragaloside IV modulates TGF-\u03b21-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"22","author":"Qian","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmc.2024.117908_b0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1874467214666210204212533","article-title":"Ticagrelor ameliorates bleomycin-induced pulmonary fibrosis in rats by the inhibition of TGF-beta1\/Smad3 and PI3K\/AKT\/mTOR pathways","volume":"15","author":"Wanas","year":"2022","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.bmc.2024.117908_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030346","article-title":"Niclosamide ethanolamine salt alleviates idiopathic pulmonary fibrosis by modulating the PI3K-mTORC1 pathway","volume":"11","author":"Pei","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bmc.2024.117908_b0125","article-title":"Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K\/Akt\/mTOR signaling pathway","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.117908_b0130","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/acel.12514","article-title":"mTORC1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts","volume":"15","author":"Romero","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.bmc.2024.117908_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116691","article-title":"Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K\/Akt signaling pathway","volume":"315","author":"Shi","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2024.117908_b0140","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jcmm.17665","article-title":"Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K\/Akt\/mTOR signalling pathway","volume":"27","author":"Li","year":"2023","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmc.2024.117908_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122218","article-title":"Eupatilin inhibits pulmonary fibrosis by activating Sestrin2\/PI3K\/Akt\/mTOR dependent autophagy pathway","volume":"334","author":"Gong","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2024.117908_b0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1165\/rcmb.2020-0143OC","article-title":"TGF-\u03b2 promotes metabolic reprogramming in lung fibroblasts via mTORC1-dependent ATF4 activation","volume":"63","author":"O\u2019Leary","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bmc.2024.117908_b0155","article-title":"Sustained PI3K activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways","volume":"6","author":"Kral","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.117908_b0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117908_b0165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.bmc.2024.117908_b0170","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bmc.2024.117908_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/srep18648","article-title":"Functions of miR-146a and miR-222 in tumor-associated macrophages in breast cancer","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bmc.2024.117908_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s40659-024-00492-3","article-title":"Glutaminolysis regulates endometrial fibrosis in intrauterine adhesion via modulating mitochondrial function","volume":"57","author":"Chen","year":"2024","journal-title":"Biol Res"},{"key":"10.1016\/j.bmc.2024.117908_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154604","article-title":"Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling","volume":"109","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bmc.2024.117908_b0190","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2023.11882","article-title":"DAB2 promotes pulmonary fibrosis and may act as an intermediate between IGF-1R and PI3K\/AKT signaling pathways","volume":"25","author":"Liang","year":"2023","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmc.2024.117908_b0195","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/jcb.25878","article-title":"The novel mTOR complex 1\/2 inhibitor P529 inhibits human lung myofibroblast differentiation","volume":"118","author":"Ferguson","year":"2017","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/j.bmc.2024.117908_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07858-8","article-title":"The mTORC1\/4E-BP1 axis represents a critical signaling node during fibrogenesis","volume":"10","author":"Woodcock","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2024.117908_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102246","article-title":"Oncoprotein DJ-1 interacts with mTOR complexes to effect transcription factor Hif1alpha-dependent expression of collagen I (alpha2) during renal fibrosis","volume":"298","author":"Das","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117908_b0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41374-020-0404-9","article-title":"PI3K-Akt-mTOR\/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis","volume":"100","author":"Hu","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.bmc.2024.117908_b0215","first-page":"779","article-title":"Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters","volume":"125","author":"Iyer","year":"1995","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.bmc.2024.117908_b0220","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3565(24)35110-9","article-title":"Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"291","author":"Iyer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2024.117908_b0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/TCRM.S81141","article-title":"Role of pirfenidone in the management of pulmonary fibrosis","volume":"13","author":"Meyer","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.bmc.2024.117908_b0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","article-title":"Effect of pirfenidone on proliferation, TGF-beta-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts","volume":"58","author":"Conte","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmc.2024.117908_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.679388","article-title":"Evaluation of pirfenidone and nintedanib in a human lung model of fibrogenesis","volume":"12","author":"Roach","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.bmc.2024.117908_b0240","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00230-2018","article-title":"Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis","volume":"52","author":"Flaherty","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.bmc.2024.117908_b0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2213-2600(21)00354-4","article-title":"Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"10","author":"Naccache","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.bmc.2024.117908_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030593","article-title":"Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets","volume":"20","author":"Ballester","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117908_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.2408","article-title":"Therapeutic strategies for idiopathic pulmonary fibrosis - thriving present and promising tomorrow","author":"Gupta","year":"2024","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.bmc.2024.117908_b0260","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01992-2018","article-title":"A randomised, placebo-controlled study of omipalisib (PI3K\/mTOR) in idiopathic pulmonary fibrosis","volume":"53","author":"Lukey","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bmc.2024.117908_b0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12890-019-0799-5","article-title":"Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K\/Akt\/mTOR and hedgehog signalling via increasing miR-193a expression","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.bmc.2024.117908_b0270","article-title":"Gypenosides attenuate pulmonary fibrosis by inhibiting the AKT\/mTOR\/c-Myc pathway","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2024.117908_b0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jphs.2019.03.002","article-title":"S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT\/NF-kappaB signaling pathway in mice","volume":"139","author":"Nie","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bmc.2024.117908_b0280","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1021\/acs.jmedchem.9b00969","article-title":"Discovery of 4-methylquinazoline based PI3K inhibitors for the potential treatment of idiopathic pulmonary fibrosis","volume":"62","author":"Lin","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117908_b0285","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1177\/1535370213498976","article-title":"Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase","volume":"238","author":"Xu","year":"2013","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.bmc.2024.117908_b0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1165\/rcmb.2017-0289OC","article-title":"Quercetin enhances ligand-induced apoptosis in senescent idiopathic pulmonary fibrosis fibroblasts and reduces lung fibrosis","volume":"60","author":"Hohmann","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bmc.2024.117908_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2023.112085","article-title":"Aspirin alleviates pulmonary fibrosis through PI3K\/AKT\/mTOR-mediated autophagy pathway","volume":"172","author":"Peng","year":"2023","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bmc.2024.117908_b0300","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1111\/jcmm.13725","article-title":"Astragaloside IV modulates TGF-beta1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"22","author":"Qian","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmc.2024.117908_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114226","article-title":"Monomeric compounds from traditional Chinese medicine: new hopes for drug discovery in pulmonary fibrosis","volume":"159","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117908_b0310","first-page":"128","article-title":"Salidroside improves pulmonary fibrosis by down-regulation of cathepsin B and NF-kappaBp65 in rats","volume":"42","author":"Liu","year":"2017","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"567","key":"10.1016\/j.bmc.2024.117908_b0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3724","article-title":"Targeted inhibition of PI3 kinase\/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models","volume":"12","author":"Hettiarachchi","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmc.2024.117908_b0320","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-12-0563","article-title":"Combined PI3K\/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models","volume":"18","author":"Roberts","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2024.117908_b0325","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.2147\/OTT.S189032","article-title":"Oral PI3K-delta, gamma inhibitor for the management of people with chronic lymphocytic leukemia and small lymphocytic lymphoma: a narrative review on duvelisib","volume":"14","author":"Shah","year":"2021","journal-title":"Oncotargets Ther"},{"key":"10.1016\/j.bmc.2024.117908_b0330","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1021\/acs.jmedchem.9b01736","article-title":"Design, synthesis, and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3K\/mTOR dual inhibitors","volume":"63","author":"Yu","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117908_b0335","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1021\/acs.jmedchem.1c02162","article-title":"Rational design and pharmacomodulation of protein-binding theranostic radioligands for targeting the fibroblast activation protein","volume":"65","author":"Meng","year":"2022","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2024.117908_b0340","doi-asserted-by":"crossref","DOI":"10.1089\/rej.2006.9.169","article-title":"Extracellular redox state: refining the definition of oxidative stress in aging","volume":"9","author":"Jones","year":"2006","journal-title":"Rejuvenat Res"},{"key":"10.1016\/j.bmc.2024.117908_b0345","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10787-016-0286-z","article-title":"Curcumin inhibits paraquat induced lung inflammation and fibrosis by extracellular matrix modifications in mouse model","volume":"24","author":"Tyagi","year":"2016","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bmc.2024.117908_b0350","article-title":"Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K\/Akt\/mTOR and hedgehog signalling via increasing miR-193a expression","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Pulmon Med"},{"key":"10.1016\/j.bmc.2024.117908_b0355","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2416132","article-title":"Meta-analysis of clinical efficacy and safety of ligustrazine in the treatment of idiopathic pulmonary fibrosis","volume":"2020","author":"Wu","year":"2020","journal-title":"Evid Based Complem Alternat Med"},{"key":"10.1016\/j.bmc.2024.117908_b0360","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1021\/jf3002685","article-title":"Nuclear factor kappaB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice","volume":"60","author":"Mong","year":"2012","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmc.2024.117908_b0365","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00394-018-1795-x","article-title":"Restorative potentiality of S-allylcysteine against diabetic nephropathy through attenuation of oxidative stress and inflammation in streptozotocin-nicotinamide-induced diabetic rats","volume":"58","author":"Sathibabu Uddandrao","year":"2019","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.bmc.2024.117908_b0370","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1160\/TH03-03-0136","article-title":"Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression","volume":"90","author":"Zhang","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bmc.2024.117908_b0375","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10753-016-0420-5","article-title":"Inhibitory effects of astragaloside IV on bleomycin-induced pulmonary fibrosis in rats via attenuation of oxidative stress and inflammation","volume":"39","author":"Yu","year":"2016","journal-title":"Inflammation"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:57:42Z","timestamp":1738162662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624003225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":75,"alternative-id":["S0968089624003225"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117908","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the PI3K\/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117908"}}